Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene related to the IMP1 gene, which itself encodes a subunit of the mitochondrial inner membrane peptidase involved in the processing of proteins targeted to the mitochondrial intermembrane space. However, as a pseudogene, ENSG00000267184 does not encode a functional protein, does not serve as a therapeutic target, and is not implicated in biological functions, disease roles, or drug interactions. Pseudogenes are generally regarded as non-functional remnants of genes that may have homology to protein-coding genes but lack the ability to produce a functional product due to disruptions in coding sequence or regulatory elements[2][7]. There is no evidence that this pseudogene is used as a biomarker or presents safety concerns, and it should not be regarded as a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IMP1 inner mitochondrial membrane peptidase-like pseudogene.